Aurinia Pharmaceuticals' (AUPH) CEO Bought 815,000 Shares for $12.5 Million

814,606 common shares acquired for a total transaction value of approximately $12.5 million, based on a weighted average price of $15.29 per share. The purchase represents 6.66% of Kevin Tang's total holdings prior to the transaction, with direct ownership unchanged at zero shares post-transaction.